CAS: 364-22-7; 2-Fluoronicotinamide

该化合物是一种有机化合物,其特点是其环结构,包括氟原子和一个碳本沙米功能组;氟原子存在于环的2个位置,影响其化学反应和极度,使其成为医药化学和农用化学和农用化学的一个有用建筑块; 碳本沙米组有助于其氢联结能力,增强极地溶剂中的溶解性; 这种化合物一般在标准条件下具有中等稳定性,但可能同时受到芳香化合物和氨的典型反应,例如电益替代和水解等; 其独特的结构特征使其得以参与各种化学反应,使其在合成更复杂的分子中具有价值; 此外,2-全氟丙烯-3-碳本沙米可能会展示生物活动,可在制药应用中加以探讨.

结构式图片

相似化合物

3939-13-7 859164-64-0 205744-16-7

欧盟法规

C&L通报

上下游产品

CAS号393-55-5 2-氟烟酸 | CAS号119899-26-2 2-氟烟酰氯 | CAS号1603-40-3 2-氨基-3-甲基吡啶 | CAS号2369-18-8 2-氟-3-甲基吡啶 | CAS号446-26-4 2-氟烟酸甲酯 | CAS号5345-47-1 2-氨基烟酸 | CAS号609-71-2 2-羟基烟酸 | CAS号10128-92-4 3-Pyridinecarbo...

合成工艺路线路线简述

    📜2-氨基-3-甲基吡啶置于potassium Permanganate,Tetrafluoroboric Acid,氯化亚砜,氨,Sodium Nitrite,苯体系中,化学反应生成2-氟烟酰胺
    参考文献:Synthesis Of 2-And 6-Fluoronicotinamides
    标题:Synthesis Of 2-And 6-Fluoronicotinamides
    摘要:
    Doi:10.1021/ja01171A518

    海关参考信息

    专利信息


    专利号:US-12391691-B2
    优先权日:2018-11-16
    标题:Synthesis of key intermediate of KRAS G12C inhibitor compound
    发明人:PARSONS ANDREW THOMAS; COCHRAN BRIAN MCNEIL; POWAZINIK IV WILLIAM; CAPORINI MARC ANTHONY
    权利人:AMGEN INC
    摘要:The present invention relates to an improved, efficient, scalable process to prepare intermediate compounds, such as compound 5M, having the structure n nuseful for the synthesis of compounds that target KRAS G12C mutations, such as

    专利号:US-2025206736-A1
    优先权日:2019-11-14
    标题 :Synthesis of kras g12c inhibitor compound
    发明人:CORBETT MICHAEL THOMAS; CAILLE SEBASTIEN
    权利人:AMGEN INC
    摘要:The present disclosure relates to an improved, efficient, scalable process to prepare intermediate compounds, such as 2-isopropyl-4-methylpyridin-3-amine, useful for the synthesis of compounds, such as Compound 9, for the treatment of KRAS G12C mutated cancers.

    专利号:US-2023192682-A1
    优先权日:2019-11-14
    标题:Improved synthesis of kras g12c inhibitor compound

    专利号:US-2023192681-A1
    优先权日:2019-11-14
    标 题 :Improved synthesis of kras g12c inhibitor compound

    专利号:US-11299491-B2
    优先权日:2018-11-16
    标 题:Synthesis of key intermediate of KRAS G12C inhibitor compound

    专利号:US-2025206735-A1
    优先权日:2018-11-16
    标题:Synthesis of key intermediate of kras g12c inhibitor compound

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1186/s13550-017-0311-2
    摘要:Garg PK, Nazih R, Wu Y, Grinevich VP, Garg S. Selective targeting of melanoma using N-(2-diethylaminoethyl) 4-[18F]fluoroethoxy benzamide (4-[18F]FEBZA): a novel PET imaging probe. EJNMMI Research. 2017 Aug 08;7(1):61. doi: 10.1186/s13550-017-0311-2.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知